Us Bancorp \De\ Kaleido Biosciences, Inc. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.05 - $1.7 $150 - $5,100	-3,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.39 - $6.02 $4,780 - $12,040	2,000 Added 200.0%	3,000 $7,000
Q1 2021 Apr 28, 2021	SELL	$7.2 - $16.82 $7,200 - $16,820	-1,000 Reduced 50.0%	1,000 $8,000
Q3 2020 Nov 10, 2020	BUY	$5.09 - $11.07 $6,362 - $13,837	1,250 Added 166.67%	2,000 $22,000
Q1 2020 May 13, 2020	BUY	$3.62 - $9.49 $724 - $1,898	200 Added 36.36%	750 $5,000
Q3 2019 Nov 08, 2019	BUY	$6.74 - $11.3 $3,707 - $6,215	550 New	550 $4,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.